Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propionibacterium extract gel for post-hemorrhoidectomy healing
NCT06872151Phase 4Completed
- Sponsor
- Università degli Studi di Cagliari
- Start
- Mar 2025
- Primary completion
- Mar 2025
- Modality
- Whole Cell Cancer Vaccines, Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of propionibacterium extract in postoperative wound, sponsored by Università degli Studi di Cagliari. Started Mar 2025; status: completed.
02
Drugs
propionibacterium extract
03
Conditions
postoperative wound
Beyond the preview
Go deeper on NCT06872151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06872151.